First inclusions REPEAT-AF: Start of the first national, registry-based randomised clinical trial
September saw the first inclusion for REPEAT-AF, an innovative study on the use of pulsed field ablation in reinterventions for atrial fibrillation (AF). This marks a new milestone in cardiovascular clinical research: it is the first registration-based, randomised clinical trial (RB-RCT) in Dutch cardiology. ‘So far, we have included 20 patients and we find that, […]
Invite: Seminar SELEQT-HF
Can intervention with Q10 and selenium slow down the ageing process, prevent cardiovascular disease and improve quality of life? An investigator meeting will be organised for SELEQT-HF in collaboration with Pharma Nord on Tuesday evening 4 February 2025 from 17:00. SELEQT-HF is the first registration-based randomised controlled trial within the Heart4Data consortium of the DCVA. […]